Skip to main content

Day: October 21, 2025

BGIN BLOCKCHAIN LIMITED Announces Pricing of Initial Public Offering

SINGAPORE, Oct. 20, 2025 (GLOBE NEWSWIRE) — BGIN BLOCKCHAIN LIMITED (“BGIN” or “the Company”) (Nasdaq: BGIN), a digital asset technology company with proprietary cryptocurrency-mining technologies, today announced the pricing of its initial public offering (the “Offering”) of 5,000,000 Class A ordinary shares, at an initial public offering price of US$6.00 per share. The Class A ordinary shares have been approved for listing on the Nasdaq Global Market and are expected to begin trading on October 21, 2025, under the symbol “BGIN.” The total gross proceeds to the Company from the Offering are expected to be approximately US$30 million, before deducting underwriting discounts and other related expenses. The Company has granted the underwriters an over-allotment option, exercisable within 45 days after the closing of this Offering,...

Continue reading

The 6th Annual Seedly Personal Finance Festival Rallies Over 3,800 Singaporeans to Offer Insights into Economic Volatility

MoneyHero strengthens brand leadership and monetisation with 3,800-attendee Seedly Personal Finance Festival in Singapore Strong attendance signals strong demand for financial guidance amid economic uncertainty The Seedly x SingSaver Personal Finance Festival featured over 65 speakers, including Acting Minister for Transport and Senior Minister of State for Finance Jeffrey SiowSINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (“MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia, today announced the successful conclusion of the Seedly x SingSaver Personal Finance Festival (PFF), which attracted more than 3,800 attendees at the Marina Bay Sands Expo & Convention Centre. Now in its sixth...

Continue reading

BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) — BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate 15,000,000 shares of common stock of BrightSpring. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering. The offering is expected to close on October 22, 2025, subject to customary closing conditions. In addition, the Company has authorized, subject to the completion...

Continue reading

Grupo Aeroportuario del Pacifico Announces Results for the Third Quarter of 2025

GUADALAJARA, Mexico, Oct. 20, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the third quarter ended September 30, 2025 (3Q25). Figures are unaudited and prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Summary of Results 3Q25 vs. 3Q24The sum of aeronautical and non-aeronautical services revenues increased by Ps. 1,174.0 million, or 17.4%. Total revenues increased by Ps. 1,343.9 million, or 16.3%.Cost of services increased by Ps. 201.8 million, or 14.1%.Income from operations increased by Ps. 429.6 million, or 11.5%.EBITDA increased by Ps. 578.0 million, or 12.8%, an increase from Ps. 4,507.6 million in 3Q24 to Ps. 5,085.6...

Continue reading

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that a press release that had previously been issued on April 17, 2025 was re-issued in error today. Please disregard this prior press release.   XORTX announces that it received today a notice (the “Extension Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180-day extension to regain compliance with the minimum bid price requirement (“Minimum Bid Requirement”) of US$1.00 per share under the Nasdaq Rule 5550(a)(2). The Company was first notified by Nasdaq that is was non-compliant with the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.